Interferon-γ release assays: New diagnostic tests for Mycobacterium tuberculosis infection, and their use in children

Deborah Lewinsohn, Mark N. Lobato, John A. Jereb

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Purpose of Review: The testing and treatment of children at risk for Mycobacterium tuberculosis infection represents an important public health priority in the United States. Until recently, diagnosis has relied upon the tuberculin skin test (TST). New interferon-γ release assays (IGRAs) offer improvements over TST, but these tests have not been studied in children until recently. RecentFindings: Evidence regarding IGRA performance in children is accumulating rapidly. Overall, the findings demonstrate performance of IGRAs equivalent or superior to that of the TST. However, IGRAs have biological limitations similar to TST and some technical problems of their own, and critical gaps in our knowledge remain. Summary: Current evidence supports usage of IGRAs in children aged 5 years or older. IGRAs are preferred over TST when specificity is paramount or wherein patients might fail to return for TST reading. Evidence for use in children aged less than 5 years is insufficient at this time: the sensitivity is poorly defined, and TST is preferred for testing these children. Future IGRA research should focus on children aged less than 5 years for informing expanded usage in this vulnerable population.

Original languageEnglish (US)
Pages (from-to)71-76
Number of pages6
JournalCurrent Opinion in Pediatrics
Volume22
Issue number1
DOIs
StatePublished - Feb 2010

Fingerprint

Tuberculin Test
Mycobacterium Infections
Skin Tests
Mycobacterium tuberculosis
Routine Diagnostic Tests
Interferons
Health Priorities
Vulnerable Populations
Reading
Public Health
Research

Keywords

  • Child
  • Diagnosis
  • Infant
  • Mycobacterium tuberculosis
  • Tuberculosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Interferon-γ release assays : New diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. / Lewinsohn, Deborah; Lobato, Mark N.; Jereb, John A.

In: Current Opinion in Pediatrics, Vol. 22, No. 1, 02.2010, p. 71-76.

Research output: Contribution to journalArticle

@article{d371a040472e4e5c98d1c60595716142,
title = "Interferon-γ release assays: New diagnostic tests for Mycobacterium tuberculosis infection, and their use in children",
abstract = "Purpose of Review: The testing and treatment of children at risk for Mycobacterium tuberculosis infection represents an important public health priority in the United States. Until recently, diagnosis has relied upon the tuberculin skin test (TST). New interferon-γ release assays (IGRAs) offer improvements over TST, but these tests have not been studied in children until recently. RecentFindings: Evidence regarding IGRA performance in children is accumulating rapidly. Overall, the findings demonstrate performance of IGRAs equivalent or superior to that of the TST. However, IGRAs have biological limitations similar to TST and some technical problems of their own, and critical gaps in our knowledge remain. Summary: Current evidence supports usage of IGRAs in children aged 5 years or older. IGRAs are preferred over TST when specificity is paramount or wherein patients might fail to return for TST reading. Evidence for use in children aged less than 5 years is insufficient at this time: the sensitivity is poorly defined, and TST is preferred for testing these children. Future IGRA research should focus on children aged less than 5 years for informing expanded usage in this vulnerable population.",
keywords = "Child, Diagnosis, Infant, Mycobacterium tuberculosis, Tuberculosis",
author = "Deborah Lewinsohn and Lobato, {Mark N.} and Jereb, {John A.}",
year = "2010",
month = "2",
doi = "10.1097/MOP.0b013e3283350301",
language = "English (US)",
volume = "22",
pages = "71--76",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Interferon-γ release assays

T2 - New diagnostic tests for Mycobacterium tuberculosis infection, and their use in children

AU - Lewinsohn, Deborah

AU - Lobato, Mark N.

AU - Jereb, John A.

PY - 2010/2

Y1 - 2010/2

N2 - Purpose of Review: The testing and treatment of children at risk for Mycobacterium tuberculosis infection represents an important public health priority in the United States. Until recently, diagnosis has relied upon the tuberculin skin test (TST). New interferon-γ release assays (IGRAs) offer improvements over TST, but these tests have not been studied in children until recently. RecentFindings: Evidence regarding IGRA performance in children is accumulating rapidly. Overall, the findings demonstrate performance of IGRAs equivalent or superior to that of the TST. However, IGRAs have biological limitations similar to TST and some technical problems of their own, and critical gaps in our knowledge remain. Summary: Current evidence supports usage of IGRAs in children aged 5 years or older. IGRAs are preferred over TST when specificity is paramount or wherein patients might fail to return for TST reading. Evidence for use in children aged less than 5 years is insufficient at this time: the sensitivity is poorly defined, and TST is preferred for testing these children. Future IGRA research should focus on children aged less than 5 years for informing expanded usage in this vulnerable population.

AB - Purpose of Review: The testing and treatment of children at risk for Mycobacterium tuberculosis infection represents an important public health priority in the United States. Until recently, diagnosis has relied upon the tuberculin skin test (TST). New interferon-γ release assays (IGRAs) offer improvements over TST, but these tests have not been studied in children until recently. RecentFindings: Evidence regarding IGRA performance in children is accumulating rapidly. Overall, the findings demonstrate performance of IGRAs equivalent or superior to that of the TST. However, IGRAs have biological limitations similar to TST and some technical problems of their own, and critical gaps in our knowledge remain. Summary: Current evidence supports usage of IGRAs in children aged 5 years or older. IGRAs are preferred over TST when specificity is paramount or wherein patients might fail to return for TST reading. Evidence for use in children aged less than 5 years is insufficient at this time: the sensitivity is poorly defined, and TST is preferred for testing these children. Future IGRA research should focus on children aged less than 5 years for informing expanded usage in this vulnerable population.

KW - Child

KW - Diagnosis

KW - Infant

KW - Mycobacterium tuberculosis

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=75749112161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749112161&partnerID=8YFLogxK

U2 - 10.1097/MOP.0b013e3283350301

DO - 10.1097/MOP.0b013e3283350301

M3 - Article

C2 - 19952926

AN - SCOPUS:75749112161

VL - 22

SP - 71

EP - 76

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 1

ER -